GNLX (STOCKS)
Genelux Corporation Common Stock
$3.020000
+0.060000 (+2.03%)
Prev close: $2.960000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Thomas D. Zindrick
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $135.64M
- Employees
- 24
- P/E (TTM)
- -3.54
- P/B (TTM)
- 5.79
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.20 | $-0.18 | -0.0164 | -8.93% |
|
Dec 2025 (Q4)
|
$-0.25 | $-0.22 | -0.0273 | -12.26% |
|
Sep 2025 (Q3)
|
$-0.21 | $-0.22 | +0.0062 | +2.87% |
|
Jun 2025 (Q2)
|
$-0.20 | $-0.22 | +0.0193 | +8.80% |
Financial Statements
| Revenues | $8.00K |
| Nonoperating Income/Loss | $988.00K |
| Operating Expenses | $34.58M |
| Research and Development | $20.93M |
| Other Operating Expenses | $13.65M |
| Operating Income/Loss | -$34.57M |
| Income/Loss From Continuing Operations After Tax | -$33.58M |
| Income/Loss From Continuing Operations Before Tax | -$1.43M |
| Net Income/Loss | -$33.58M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$33.58M |
| Net Income/Loss Available To Common Stockholders, Basic | -$33.58M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.85 |
| Diluted Earnings Per Share | -$0.85 |
| Basic Average Shares | 120,299,522 |
| Diluted Average Shares | 120,299,522 |
| Assets | $32.37M |
| Current Assets | $26.75M |
| Noncurrent Assets | $5.62M |
| Fixed Assets | $3.08M |
| Other Non-current Assets | $2.54M |
| Liabilities | $9.45M |
| Current Liabilities | $7.27M |
| Noncurrent Liabilities | $2.18M |
| Equity | $22.92M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $22.92M |
| Liabilities And Equity | $32.37M |
| Net Cash Flow From Operating Activities | -$25.89M |
| Net Cash Flow From Operating Activities, Continuing | -$25.89M |
| Net Cash Flow From Investing Activities | $93.00K |
| Net Cash Flow From Investing Activities, Continuing | $93.00K |
| Net Cash Flow From Financing Activities | $18.87M |
| Net Cash Flow From Financing Activities, Continuing | $18.87M |
| Net Cash Flow | -$6.93M |
| Net Cash Flow, Continuing | -$6.93M |
| Comprehensive Income/Loss | -$33.59M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$33.62M |
| Other Comprehensive Income/Loss | -$26.13M |